Global mRNA Cancer Vaccines and Therapeutics Market Research Report 2024(Status and Outlook)

Global mRNA Cancer Vaccines and Therapeutics Market Research Report 2024(Status and Outlook)



Report Overview:

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

The Global mRNA Cancer Vaccines and Therapeutics Market Size was estimated at USD 169.70 million in 2023 and is projected to reach USD 481.91 million by 2029, exhibiting a CAGR of 19.00% during the forecast period.

This report provides a deep insight into the global mRNA Cancer Vaccines and Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global mRNA Cancer Vaccines and Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the mRNA Cancer Vaccines and Therapeutics market in any manner.

Global mRNA Cancer Vaccines and Therapeutics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Moderna Therapeutics

CureVac

Translate Bio

BioNTech

Sangamo Therapeutics

Argos Therapeutics

In-Cell-Art

eTheRNA

Ethris

Tiba Biotechnology

Market Segmentation (by Type)

Adeno Carcinomas

Mucinous Carcinomas

Adenosquamous Carcinomas

Market Segmentation (by Application)

Infectious Disease

Cancer

Others

Geographic SegmentationNorth America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
    • Key Benefits of This Market Research:
    Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the mRNA Cancer Vaccines and Therapeutics Market
  • Overview of the regional outlook of the mRNA Cancer Vaccines and Therapeutics Market:
    • Key Reasons to Buy this Report:
    Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
    • Customization of the Report

      In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

      Note: this report may need to undergo a final check or review and this could take about 48 hours.

      Chapter Outline

      Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

      Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the mRNA Cancer Vaccines and Therapeutics Market and its likely evolution in the short to mid-term, and long term.

      Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

      Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

      Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

      Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

      Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

      Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

      Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

      Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

      Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

      Chapter 12 is the main points and conclusions of the report.

  • 1 Research Methodology and Statistical Scope
    1.1 Market Definition and Statistical Scope of mRNA Cancer Vaccines and Therapeutics
    1.2 Key Market Segments
    1.2.1 mRNA Cancer Vaccines and Therapeutics Segment by Type
    1.2.2 mRNA Cancer Vaccines and Therapeutics Segment by Application
    1.3 Methodology & Sources of Information
    1.3.1 Research Methodology
    1.3.2 Research Process
    1.3.3 Market Breakdown and Data Triangulation
    1.3.4 Base Year
    1.3.5 Report Assumptions & Caveats
    2 mRNA Cancer Vaccines and Therapeutics Market Overview
    2.1 Global Market Overview
    2.1.1 Global mRNA Cancer Vaccines and Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
    2.1.2 Global mRNA Cancer Vaccines and Therapeutics Sales Estimates and Forecasts (2019-2030)
    2.2 Market Segment Executive Summary
    2.3 Global Market Size by Region
    3 mRNA Cancer Vaccines and Therapeutics Market Competitive Landscape
    3.1 Global mRNA Cancer Vaccines and Therapeutics Sales by Manufacturers (2019-2024)
    3.2 Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Manufacturers (2019-2024)
    3.3 mRNA Cancer Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.4 Global mRNA Cancer Vaccines and Therapeutics Average Price by Manufacturers (2019-2024)
    3.5 Manufacturers mRNA Cancer Vaccines and Therapeutics Sales Sites, Area Served, Product Type
    3.6 mRNA Cancer Vaccines and Therapeutics Market Competitive Situation and Trends
    3.6.1 mRNA Cancer Vaccines and Therapeutics Market Concentration Rate
    3.6.2 Global 5 and 10 Largest mRNA Cancer Vaccines and Therapeutics Players Market Share by Revenue
    3.6.3 Mergers & Acquisitions, Expansion
    4 mRNA Cancer Vaccines and Therapeutics Industry Chain Analysis
    4.1 mRNA Cancer Vaccines and Therapeutics Industry Chain Analysis
    4.2 Market Overview of Key Raw Materials
    4.3 Midstream Market Analysis
    4.4 Downstream Customer Analysis
    5 The Development and Dynamics of mRNA Cancer Vaccines and Therapeutics Market
    5.1 Key Development Trends
    5.2 Driving Factors
    5.3 Market Challenges
    5.4 Market Restraints
    5.5 Industry News
    5.5.1 New Product Developments
    5.5.2 Mergers & Acquisitions
    5.5.3 Expansions
    5.5.4 Collaboration/Supply Contracts
    5.6 Industry Policies
    6 mRNA Cancer Vaccines and Therapeutics Market Segmentation by Type
    6.1 Evaluation Matrix of Segment Market Development Potential (Type)
    6.2 Global mRNA Cancer Vaccines and Therapeutics Sales Market Share by Type (2019-2024)
    6.3 Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type (2019-2024)
    6.4 Global mRNA Cancer Vaccines and Therapeutics Price by Type (2019-2024)
    7 mRNA Cancer Vaccines and Therapeutics Market Segmentation by Application
    7.1 Evaluation Matrix of Segment Market Development Potential (Application)
    7.2 Global mRNA Cancer Vaccines and Therapeutics Market Sales by Application (2019-2024)
    7.3 Global mRNA Cancer Vaccines and Therapeutics Market Size (M USD) by Application (2019-2024)
    7.4 Global mRNA Cancer Vaccines and Therapeutics Sales Growth Rate by Application (2019-2024)
    8 mRNA Cancer Vaccines and Therapeutics Market Segmentation by Region
    8.1 Global mRNA Cancer Vaccines and Therapeutics Sales by Region
    8.1.1 Global mRNA Cancer Vaccines and Therapeutics Sales by Region
    8.1.2 Global mRNA Cancer Vaccines and Therapeutics Sales Market Share by Region
    8.2 North America
    8.2.1 North America mRNA Cancer Vaccines and Therapeutics Sales by Country
    8.2.2 U.S.
    8.2.3 Canada
    8.2.4 Mexico
    8.3 Europe
    8.3.1 Europe mRNA Cancer Vaccines and Therapeutics Sales by Country
    8.3.2 Germany
    8.3.3 France
    8.3.4 U.K.
    8.3.5 Italy
    8.3.6 Russia
    8.4 Asia Pacific
    8.4.1 Asia Pacific mRNA Cancer Vaccines and Therapeutics Sales by Region
    8.4.2 China
    8.4.3 Japan
    8.4.4 South Korea
    8.4.5 India
    8.4.6 Southeast Asia
    8.5 South America
    8.5.1 South America mRNA Cancer Vaccines and Therapeutics Sales by Country
    8.5.2 Brazil
    8.5.3 Argentina
    8.5.4 Columbia
    8.6 Middle East and Africa
    8.6.1 Middle East and Africa mRNA Cancer Vaccines and Therapeutics Sales by Region
    8.6.2 Saudi Arabia
    8.6.3 UAE
    8.6.4 Egypt
    8.6.5 Nigeria
    8.6.6 South Africa
    9 Key Companies Profile
    9.1 Moderna Therapeutics
    9.1.1 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Basic Information
    9.1.2 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product Overview
    9.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product Market Performance
    9.1.4 Moderna Therapeutics Business Overview
    9.1.5 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics SWOT Analysis
    9.1.6 Moderna Therapeutics Recent Developments
    9.2 CureVac
    9.2.1 CureVac mRNA Cancer Vaccines and Therapeutics Basic Information
    9.2.2 CureVac mRNA Cancer Vaccines and Therapeutics Product Overview
    9.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Product Market Performance
    9.2.4 CureVac Business Overview
    9.2.5 CureVac mRNA Cancer Vaccines and Therapeutics SWOT Analysis
    9.2.6 CureVac Recent Developments
    9.3 Translate Bio
    9.3.1 Translate Bio mRNA Cancer Vaccines and Therapeutics Basic Information
    9.3.2 Translate Bio mRNA Cancer Vaccines and Therapeutics Product Overview
    9.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Product Market Performance
    9.3.4 Translate Bio mRNA Cancer Vaccines and Therapeutics SWOT Analysis
    9.3.5 Translate Bio Business Overview
    9.3.6 Translate Bio Recent Developments
    9.4 BioNTech
    9.4.1 BioNTech mRNA Cancer Vaccines and Therapeutics Basic Information
    9.4.2 BioNTech mRNA Cancer Vaccines and Therapeutics Product Overview
    9.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Product Market Performance
    9.4.4 BioNTech Business Overview
    9.4.5 BioNTech Recent Developments
    9.5 Sangamo Therapeutics
    9.5.1 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Basic Information
    9.5.2 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product Overview
    9.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product Market Performance
    9.5.4 Sangamo Therapeutics Business Overview
    9.5.5 Sangamo Therapeutics Recent Developments
    9.6 Argos Therapeutics
    9.6.1 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Basic Information
    9.6.2 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product Overview
    9.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product Market Performance
    9.6.4 Argos Therapeutics Business Overview
    9.6.5 Argos Therapeutics Recent Developments
    9.7 In-Cell-Art
    9.7.1 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Basic Information
    9.7.2 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product Overview
    9.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product Market Performance
    9.7.4 In-Cell-Art Business Overview
    9.7.5 In-Cell-Art Recent Developments
    9.8 eTheRNA
    9.8.1 eTheRNA mRNA Cancer Vaccines and Therapeutics Basic Information
    9.8.2 eTheRNA mRNA Cancer Vaccines and Therapeutics Product Overview
    9.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Product Market Performance
    9.8.4 eTheRNA Business Overview
    9.8.5 eTheRNA Recent Developments
    9.9 Ethris
    9.9.1 Ethris mRNA Cancer Vaccines and Therapeutics Basic Information
    9.9.2 Ethris mRNA Cancer Vaccines and Therapeutics Product Overview
    9.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Product Market Performance
    9.9.4 Ethris Business Overview
    9.9.5 Ethris Recent Developments
    9.10 Tiba Biotechnology
    9.10.1 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Basic Information
    9.10.2 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product Overview
    9.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product Market Performance
    9.10.4 Tiba Biotechnology Business Overview
    9.10.5 Tiba Biotechnology Recent Developments
    10 mRNA Cancer Vaccines and Therapeutics Market Forecast by Region
    10.1 Global mRNA Cancer Vaccines and Therapeutics Market Size Forecast
    10.2 Global mRNA Cancer Vaccines and Therapeutics Market Forecast by Region
    10.2.1 North America Market Size Forecast by Country
    10.2.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size Forecast by Country
    10.2.3 Asia Pacific mRNA Cancer Vaccines and Therapeutics Market Size Forecast by Region
    10.2.4 South America mRNA Cancer Vaccines and Therapeutics Market Size Forecast by Country
    10.2.5 Middle East and Africa Forecasted Consumption of mRNA Cancer Vaccines and Therapeutics by Country
    11 Forecast Market by Type and by Application (2025-2030)
    11.1 Global mRNA Cancer Vaccines and Therapeutics Market Forecast by Type (2025-2030)
    11.1.1 Global Forecasted Sales of mRNA Cancer Vaccines and Therapeutics by Type (2025-2030)
    11.1.2 Global mRNA Cancer Vaccines and Therapeutics Market Size Forecast by Type (2025-2030)
    11.1.3 Global Forecasted Price of mRNA Cancer Vaccines and Therapeutics by Type (2025-2030)
    11.2 Global mRNA Cancer Vaccines and Therapeutics Market Forecast by Application (2025-2030)
    11.2.1 Global mRNA Cancer Vaccines and Therapeutics Sales (K Units) Forecast by Application
    11.2.2 Global mRNA Cancer Vaccines and Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
    12 Conclusion and Key Findings

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook
    Cookie Settings